StockData

Aspira Women's Health Inc. (AWHL) income statement

AWHLOTCIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.22−0.01 (-2.61%)

Close on Oct 19, 2026Market cap $9.91MP/E –Yield –

Aspira Women's Health Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
2954.7%
Operating margin
-4059.4%
Net margin
-5885.3%
Return on equity, FY2025
269.2%

Financial strength

Current ratio
0.52
Debt to equity
-0.23
Debt to assets
38.4%
Cash to current liabilities
8.9%

Valuation

P/E ratio
–
Price to sales
58.31
Price to book
–
Dividend yield
–

See a number that looks wrong?